Frontline Treatment of Acute Myeloid Leukemia in Adults Long-Term Results in a Mexican Medical Center

Alvarado Ibarra Martha, Guerra Alarcón Lidia Virginia, Mena Zepeda Verónica, Ortiz Zepeda Maricela, Espitia Ríos Eugenia, à lvarez Vera José Luis, Antonio De la Peña Celaya and López Hernández Manuel Antonio
Additional contact information
López Hernández Manuel Antonio: Hematology Service, National Medical Center, Mexico

Cancer Therapy & Oncology International Journal, 2018, vol. 10, issue 5, 86-94

Abstract: Acute myeloid leukemias were previously known as a single disease, they are a heterogeneous group of diseases with different morphological characteristics and several genetic alterations that are related to prognosis, in general the five years overall survival for patients with de novo Acute Myeloid Leukemia (AML) is only 25% according to Surveillance, Epidemiology, and End Results Program (SEER) from United States of America. Standard chemotherapy for this type of leukemia with best results is those schemes based on cytarabine and anthracycline administration achieving Complete Response (CR) rates of 85%.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555800.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555800.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:10:y:2018:i:5:p:86-94

DOI: 10.19080/CTOIJ.2018.10.555800

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().